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Abstract— We report here a simple entry into naphtho[2,3-d]isoxazole-4,9-dione system containing a EWG in position 3 using the 
readily available 2,3-dichloro-1,4-naphthoquinone and nitromethyl derivatives in the presence of base. Antifungal activity of synthesised 
naphthoquinones was evaluated against ATCC and PYCC reference strains of Candida. The results suggest that the naphtho[2,3-
d]isoxazole-4,9-dione scaffold has the potential to be developed into novel and safe therapeutic antifungal agents. 
Compounds containing the quinone group represent 
an important class of biologically active molecules 
that are widespread in nature.1 Isoxazoles also have a 
significant number of biological applications, 
displaying hypoglycemic, analgesic, anti-
inflammatory, antifungal, anti-bacterial and HIV-
inhibitory activity.2 Naphtho[2,3-d]isoxazole-4,9-
diones 1 (Figure 1) combine both functionalities and 
are an attractive target. Importantly, compounds 1 
also display agricultural applications.3  
 
 
 
Figure 1. Structure of compounds 1 and 4. 
To date, most of the routes to naphtho[2,3-d]isoxazole-
4,9-diones described in the literature use in situ 
generation of nitrile oxides, require the synthesis of the 
necessary starting materials and do not allow the 
introduction of electron-withdrawing group (EWG) in 
position 3.4-6 To the best of our knowledge, there is 
only one route that introduces an ethyl ester in position 
3 of the isoxazole moiety that involves a manganese 
(III) acetate initiated reaction between readily available 
1,4-naphthoquinones and ethyl nitroacetate. This 
method is highly wasteful, requiring 8 eq. of ethyl 
nitroacetate and 12 eq. of manganese (III) acetate.7,8  
Recently we described naphtho[2,3-d]isoxazole-4,9-
dione-3-carboxylates 1a-b as potent, non-cytotoxic, 
antiapoptotic agents, through modulation of apoptotic 
pathways.9 The two compounds were synthesized from 
1 eq. of each commercially available starting material, 
2,3-dichloro-1,4-naphthoquinone 2 and a nitromethyl 
derivative 3a-b, in the presence of base (Scheme 1). By 
this method, the isoxazole 1a was obtained in 22% 
yield (35% based on recovered 2) after 3d at reflux in 
the presence of NEt3 in ethanol. Using methyl 
nitroacetate 3b the isoxazole 1b was obtained in 19% 
yield, along with the isoxazole 1a (7% yield) due to 
ester exchange, and 2-chloro-3-ethoxy-1,4-
naphthoquinone 4a (13% yield). To avoid the problem 
of ester exchange, we changed the solvent to MeOH 
but did not observe any formation of isoxazole after 3d 
at reflux (Table 1). In this case, we only isolated 2-
chloro-3-methoxy-1,4-naphthoquinone 4b (33% yield) 
- presumably due to the lower temperature of reflux.  
We then decided to continue working on this new 
methodology in order to improve the low yields of 
naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates 1a-
b. An improved synthesis was accomplished, using 
diisopropylethylamine (2 eq.) as base, in the presence 
of molecular sieves.10a In this case, the reaction 
O
O
N
O
EWG
1
O
O
4a
-
b
Cl
OR
a R=Et; b R=Me
ACCEPTED MANUSCRIPT 
 
proceeded faster with no starting material being 
recovered; after 6.5 h we isolated isoxazole 1a (33% 
yield), along with 2-chloro-3-ethoxy-1,4-
naphthoquinone 4a11 (11% yield) formed by 
substitution of a Cl atom by the solvent. Using methyl 
nitroacetate 3b the isoxazole 1b was obtained in 33% 
yield, along with 2-chloro-3-ethoxy-1,4-
naphthoquinone 4a (12% yield).10a  
 
Scheme 1. Synthesis of naphtho[2,3-d]isoxazole-4,9-diones 1a-d.  
When 2-bromo-1,4-naphthoquinone 5 was used as 
starting material, naphthoquinone 6 (78% yield) was 
obtained from reaction with 3a, after 6.5h at reflux in 
the presence of NEt3 in ethanol (Scheme 2). Only after 
29h at reflux, was the isoxazole 1a obtained (13% 
yield), along with the naphthoquinone 6 (26% 
yield).12,13 The latter obviously arises from Michael 
addition of the nitronate anion at the least substituted 
quinone carbon atom followed by loss of the nitrite ion. 
Attack at the C-H carbon is presumably preferred 
because (i) this centre is less sterically hindered, and 
(ii) bromine stabilizes an adjacent anion better than 
does an H atom.  
Scheme 2. Reactions of 2-bromo-1,4-naphthoquinone 5 and 2,3-
dichloro-5,8-dimetoxi-1,4-naphthoquinone 7 with 3a. 
When we used 2,3-dichloro-5,8-dimethoxy-1,4-
naphthoquinone 7 and 3a as starting materials, after 
1.5h at reflux in ethanol in the presence of 2 eq. of 
DIEA and molecular sieves, we isolated compound 8 
in 56% yield (Scheme 2).14 In this case, no formation 
of isoxazole was observed, even after 30 h at reflux in 
the presence of NEt3 (Table 1). 
This method seems to be general for other nitromethyl 
derivatives, as it was also possible to obtain 
naphtho[2,3-d]isoxazole-4,9-diones with a sulfone 1c 
and a ketone 1d in position 3 (Scheme 1). When 
reaction of 2 was attempted with 
phenylsulfonylnitromethane 3c or benzoylnitromethane 
3d in the presence of DIEA and ethanol, only 2-chloro-
3-ethoxy-1,4-naphthoquinone 4a, from reaction of the 
quinone with the solvent, could be isolated (Table 
1).10a However, when we changed the solvent to 
acetonitrile, it was then possible to obtain the 
isoxazoles 1c and 1d, respectively (Table 1).10b 
Isoxazole 1c was only formed in the presence of NEt3 
(10% yield). In the presence of DIEA or K2CO3 a 
complex mixture of products was obtained. Isoxazole 
1d however was obtained using as bases DABCO 
(12% yield), NEt3 (32% yield), DIEA (32% yield) or 
K2CO3 (23% yield). To try to improve the yield of 1d, 
we decided to study the effect of using 2 equivalents of 
nitroacetate 3d, however in the presence of NEt3 in 
CH3CN, we obtained a more complex mixture, and we 
could only isolate isoxazole 1d in 14% yield.  
Table 1. Reaction conditions used for the synthesis of compounds 1a-d, 
6 and 8. 
Starting materials Solvent Base Reflux 
(h) 
Product 
(Yield) 
2 3a EtOH DIEA 6.5 1a (33%) 
4a (11%) 
5  EtOH NEt3 6.5 6 (78%) 
  EtOH NEt3 29.0 1a (13%) 
6 (26%) 
7  EtOH DIEA 1.5 8 (56%) 
  EtOH DIEA 30.0 8 (37%) 
2 3b EtOH DIEA 6.5 1b (33%) 
4a (12%) 
  MeOH NEt3 72.0 4b (33%) 
2 3c EtOH DIEA 96.0 4a (15%) 
  CH3CN NEt3 4.0 1c (10%) 
  CH3CN DIEA 2.0 ??? 
  CH3CN K2CO3 48.0 ??? 
2 3d EtOH DIEA 24.0 4a (41%) 
  CH3CN DABCO 6.0 1d (12%) 
  CH3CN NEt3 5.0 1d (32%) 
  CH3CN DIEA 4.5 1d (32%) 
  CH3CN K2CO3 5.0 1d (23%) 
 
In all the above reactions, a complex mixture of 
products was obtained, and we could only isolate as the 
major products the products described in table 1.  
Structural assignment of products 1 was based on 
spectroscopic data,16-17 which accorded with the 
literature.7 Confirmation of the isoxazole structure 1 
came from the X-ray crystallographic analysis.18 
Naphtho[2,3-d]isoxazole-4,9-diones 1a-d and 
naphthoquinones 4a-b, 6 and 8 were evaluated for their 
antifungal activity against various ATCC and PYCC 
reference strains of Candida.19 The MIC50 values were 
calculated using probit analysis based on triplicate 
assays and are presented in Table 2. All compounds 
showed a reasonable level of antifungal activity at the 
µg/mL level, ranging from the lowest MIC50 value of 
0.2 µg/mL for compound 1a against PYCC 2545 (C. 
parapsilosis) and PYCC 2418T (C. glabrata) to the 
highest of 47.9 µg/mL for compound 4a against ATCC 
90028 (C. albicans).  
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Table 2. Determination of MIC50 µg/mL (µM) for compounds 1a-d, 4a-b, 6 and 8. 
Compound C. albicans C. albicans C. krusei C. parapsilosis C. parapsilosis C. glabrata 
 ATCC 90028 PYCC 3436T PYCC 3341 PYCC 2545 ATCC 22019 PYCC 2418T 
1a 3.1 (11.5) 0.5 (1.8) 0.6 (2.3) 0.2 (0.6) 0.5 (1.7) 0.2 (0.6) 
1b 3.1 (12.2) 0.2 (0.7) 0.6 (2.4) 0.3 (1.3) 0.5 (1.8) 0.7 (2.6) 
1c 19.2 (56.7) 0.8 (2.5) 3.3 (9.7) 0.5 (1.6) 2.1 (6.1) 0.5 (1.5) 
1d 21.6 (71.2) 0.5 (1.6) 6.4 (21.2) 4.0 (13.2) 1.0 (3.3) 14.4 (47.6) 
4a 47.9 (202.4) 2.3 (9.5) 0.9 (3.9) 11.4 (48.3) 9.6 (40.4) 0.9 (3.8) 
4b 16.5 (73.9) 2.3 (10.4) 1.0 (4.6) 1.2 (5.3) 1.0 (4.7) 3.7 (16.7) 
6 1.5 (4.5) 0.3 (0.9) nda 0.4 (1.1) 1.0 (3.2) 3.9 (12.0) 
8 25.7 (56.0) 5.6 (12.2) 3.0 (6.5) 7.0 (15.2) 8.4 (18.4) 2.3 (5.1) 
AmpB 1.1 (1.2) 0.5 (0.5) 0.9 (1.0) 0.4 (0.5) 0.4 (0.5) 0.3 (0.4) 
a) Not determinate due to absence of yeast growth in all bioassays. 
 
Inspection of the data in Table 2, allows the following 
observations to be made: 
1. There was marked variability among the strains 
with regard to their susceptibilities to the various test 
compounds. This is particularly evident for the C. 
albicans ATCC 90028 and PYCC 3436T strains (e.g. 
compounds 1c, 1d and 4a). Such variability suggests 
there are biological factor(s) affecting strain/species and 
test compound bioactivity.  
2. Strain ATCC 90028 appeared to be the least 
sensitive, to almost all the compounds. Only compound 
6, with an MIC50 of 1.5 µg/mL demonstrated antifungal 
activity equivalent to that of AmpB (Amphotericin B) 
for this strain. In addition, this compound also had 
notable activity against PYCC strains 2545 and 3436T. 
3. Only compounds 1a and 1b showed a level of 
activity equivalent to that of AmpB against strain 
ATCC 22019. Compound 1a appeared to have the 
broadest antifungal activity, showing MIC50 values at or 
below that of AmpB for all strains, except ATCC 
90028. Compound 1b was next in breadth of activity, 
with MIC50 values at or below those of AmpB for four 
of the six strains. Compound 1c demonstrated 
reasonable antifungal activity, with MIC50 levels 
<1.0µg/mL against PYCC strains, 2545, 3436T and 
2418T. 
4. The order of the antifungal activity in 
compounds 1 seems to depend on the nature of the 
EWG in position 3 and varies in the order ester › sulfone 
› ketone. 
5. Compounds 1d, 4a and 4b, also showed 
reasonable antifungal activities equivalent to that of 
AmpB against one strain, each. Compound 8, although 
exhibiting fair antifungal activity at the µg/mL level 
against all strains, did not present any MIC50 values at 
or below that of AmpB against any of the strains.  
 
In summary, we describe a new methodology for the 
synthesis of isoxazoles 1 containing an EWG in 
position 3. Although the yields are lower than those 
described for the synthesis of isoxazole 1a (lit. 55% 
yield),7 our procedure uses cleaner chemistry and only 
1 equivalent of both commercial starting materials. 
Also, our method is not restricted to the use of ethyl 
nitroacetate, but seems to be general for other 
nitromethyl derivatives. In addition, all the test 
compounds showed effective levels of antifungal 
activity at the µg/mL level. Importantly, 1a and 1b 
showed the broadest activity and were equivalent to or 
better than the standard antifungal drug Amphotericin 
B against five of the six strains examined. The 
observation that naphtho[2,3-d]isoxazole-4,9-dione-3-
carboxylates 1a-b are non-cytotoxic in human cellular 
lines9 strongly suggests that the naphtho[2,3-
d]isoxazole-4,9-dione scaffold has the potential to be 
developed into novel and safe therapeutic antifungal 
agents. The mechanism for the formation of isoxazoles 
1a-d is understudy. 
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